English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
CDK inhibitors from past to present: A new wave of cancer therapy Journal article
Muhammad Jameel Mughal, Kinjal Bhadresha, Hang Fai Kwok. CDK inhibitors from past to present: A new wave of cancer therapy[J]. Seminars in Cancer Biology, 2023, 88, 106-122.
Authors:  Muhammad Jameel Mughal;  Kinjal Bhadresha;  Hang Fai Kwok
Favorite | TC[WOS]:37 TC[Scopus]:36  IF:12.1/13.2 | Submit date：2023/02/08
Cancer Therapeutic Regimen  Cell Cycle  Combination Treatment  Cyclin-dependent Kinase Inhibitor  
The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition Journal article
Xia Q., Cai Y., Peng R., Wu G., Shi Y., Jiang W.. The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition[J]. International Journal of Oncology, 2014, 44(3), 735.
Authors:  Xia Q.;  Cai Y.;  Peng R.;  Wu G.;  Shi Y.; et al.
Favorite | TC[WOS]:45 TC[Scopus]:49 | Submit date：2018/10/30
Brca1  Breast Cancer  Cyclin-dependent Kinase 1  Poly (Adp-ribose) Polymerase Inhibitor